Developing a successful market access strategy requires navigating complex payer and health technology assessment (HTA) requirements, often across product classes and therapeutic areas.

HTE can help you develop a strategic roadmap to effectively demonstrate and communicate your product’s clinical and economic value as well as unmet medical need. We have extensive research experience and knowledge of market access and regulatory landscape to help you better understand what shapes decision making and, ultimately, overcome HTA and payer challenges ensuring optimal pricing and access.

To determine your best commercialization strategy, the team of HTE is highly skilled and experienced in:

• HTA submission dossiers and support (early & post-submission)
• HTA landscape assessments
• Evidence gap analysis
• Stakeholder mapping & engagement (workshops, panels, advisory boards)
• Market access strategy development & evidence generation planning
• Managed entry agreements and negotiation plans